{"id":21110,"date":"2021-02-16T15:01:00","date_gmt":"2021-02-16T15:01:00","guid":{"rendered":"https:\/\/celonpharma.com\/?p=21110"},"modified":"2021-02-16T15:01:00","modified_gmt":"2021-02-16T15:01:00","slug":"current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/","title":{"rendered":"Current report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">February 16, 2021<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information<br>Content of the report:<br>Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby publishes the text of the resolutions adopted by the Extraordinary General Meeting of the Company on February 16, 2021 along with appendices thereto.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Since the electronic vote-counting system was used, no resolution on the election of the Returning Committee has been adopted. No item on the agenda has been withdrawn and no objection to any of the adopted resolutions has been raised.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">(<a href=\"http:\/\/celon.group\/wp-content\/uploads\/2021\/06\/Uchwaly_NWZ_Celon_Pharma_SA_16-02-2021.pdf\">Resolutions of the Extraordinary General Meeting of Celon Pharma S.A. held on February 16, 2021)<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">(<a href=\"http:\/\/celon.group\/wp-content\/uploads\/2021\/06\/Zalacznik_do_uchwaly_nr_4_NWZ_Celon_Pharma_SA_16-02-2021_Opinia_Zarzadu.pdf\">Appendix to the Resolution No. 4 of the Extraordinary General Meeting of Celon Pharma S.A. held on February 16, 2021; Opinion of the Management Board)<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/celon.group\/wp-content\/uploads\/2021\/06\/Zalacznik_do_uchwaly_nr_6_i_7_NWZ_Celon_Pharma_SA_16-02-2021_Uzasadnienie.pdf\"> (Appendix to Resolutions No. 6 and 7 of the Extraordinary General Meeting of Celon Pharma S.A. held on February 16, 2021; Justification)<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/celon.group\/wp-content\/uploads\/2021\/06\/Zalacznik_do_uchwaly_nr_8_NWZ_Celon_Pharma_SA_16-02-2021_Polityka_wynagrodzen.pdf\"> (Appendix to Resolutions No. 6 and 7 of the Extraordinary General Meeting of Celon Pharma S.A. held on February 16, 2021; Justification)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>February 16, 2021 Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical informationContent of the report:Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby publishes the text of the resolutions adopted by the Extraordinary General Meeting of the Company on February 16, 2021 along with appendices<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/\" title=\"ReadCurrent report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[25],"tags":[],"class_list":["post-21110","post","type-post","status-publish","format-standard","hentry","category-current-report"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Current report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021 - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Current report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021 - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"February 16, 2021 Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical informationContent of the report:Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby publishes the text of the resolutions adopted by the Extraordinary General Meeting of the Company on February 16, 2021 along with appendicesRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-16T15:01:00+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/\",\"url\":\"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/\",\"name\":\"Current report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021 - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2021-02-16T15:01:00+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Current report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Current report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021 - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/","og_locale":"en_US","og_type":"article","og_title":"Current report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021 - CelonGROUP","og_description":"February 16, 2021 Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical informationContent of the report:Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby publishes the text of the resolutions adopted by the Extraordinary General Meeting of the Company on February 16, 2021 along with appendicesRead more &raquo;","og_url":"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/","og_site_name":"CelonGROUP","article_published_time":"2021-02-16T15:01:00+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/","url":"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/","name":"Current report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021 - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2021-02-16T15:01:00+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/celon.group\/en\/2021\/02\/16\/current-report-no-9-2021-resolutions-adopted-by-the-extraordinary-general-meeting-of-celon-pharma-s-a-on-february-16-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Current report No. 9\/2021 \u2013 Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/21110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=21110"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/21110\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=21110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=21110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=21110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}